Pharm'Up 
A new study published in Acta Pharmacologica Sinica has used a powerful machine learning framework to find a new way to treat hyperlipidemia, or high cholesterol. This groundbreaking research identified 29 FDA-approved drugs that were not originally intended to lower lipids but could potentially be repurposed for this use. This discovery offers a promising solution for patients who can’t tolerate or don’t respond well to traditional therapies like statins.
The Urgent Need for New Treatments
Hyperlipidemia is a major health concern, with the American Heart Association reporting that a significant portion of the US population has elevated cholesterol levels, increasing the risk of cardiovascular disease. While many effective lipid-lowering drugs are available, some patients experience side effects or find them ineffective. This makes the search for new treatment options a top priority.
AI-Driven Drug Discovery
Researchers built a sophisticated machine learning model to analyze over 3,400 drugs. The model successfully identified 29 FDA-approved medications that could have lipid-lowering effects. The team then went a step further, validating these findings through both clinical data analysis and animal experiments.
- Clinical Validation: A review of patient records showed that four of the identified drugs—argatroban, levothyroxine sodium, oseltamivir, and thiamine—meaningfully altered blood lipid levels. Argatroban was particularly effective, showing the most significant impact on LDL (“bad”) cholesterol and triglycerides.
- Experimental Validation: In a series of mouse experiments, levothyroxine sodium and sulfaphenazole were confirmed to lower triglycerides. Other drugs, including prasterone, were found to significantly raise levels of HDL (“good”) cholesterol.
The Future of Medicine is Here
According to Dr. Peng Luo, a senior author on the study, this AI-driven approach is a game-changer. It allows researchers to bypass the traditional, time-consuming drug development process, offering clinicians new tools “faster and cheaper.” These repurposed drugs could be used alone or in combination with existing medications to improve patient outcomes, opening a new chapter in the fight against high cholesterol.
About the Author
